{"id":119,"date":"2014-03-13T10:11:40","date_gmt":"2014-03-13T15:11:40","guid":{"rendered":"https:\/\/deltadermpath.com\/?page_id=119"},"modified":"2014-05-06T10:15:03","modified_gmt":"2014-05-06T15:15:03","slug":"news","status":"publish","type":"page","link":"https:\/\/deltadermpath.com\/?page_id=119","title":{"rendered":"News"},"content":{"rendered":"<h4><a title=\"Melanoma FISH Test\" href=\"https:\/\/deltadermpath.com\/index.php\/melanoma-fish-test\/\"><span style=\"color: #3366ff;\">MELANOMA FISH TEST<\/span><\/a><\/h4>\n<p>We are pleased to announce that we now offer fluorescent in situ hybridization (FISH) testing as a diagnostic tool to aid in the classification of histologically ambiguous melanocytic lesions. The test is offered through our molecular pathology\/cytogenetics division, Delta MDx (www.DeltaMDx.com). Background The vast majority of benign nevi can be distinguished from malignant melanoma on the basis of standard histologic criteria. However, a subset of melanocytic lesions presents a diagnos&#8230; \u00a0\u00a0<a title=\"Melanoma FISH Test\" href=\"https:\/\/deltadermpath.com\/index.php\/melanoma-fish-test\/\"><span style=\"color: #3366ff;\">read more &gt;&gt;<\/span><\/a><\/p>\n<h4><a title=\"Immunohistochemical Screening for Muir-Torre Syndrome\" href=\"https:\/\/deltadermpath.com\/index.php\/immunohistochemical-screening-for-muir-torre-syndrome\/\"><span style=\"color: #3366ff;\">IMMUNOHISTOCHEMICAL SCREENING FOR MUIR-TORRE SYNDROME<\/span><\/a><\/h4>\n<p>We are now offering immunohistochemical staining for MLH-1, MSH-2 and MSH-6, which may be employed as an initial screening test to help identify patients who may have Muir-Torre syndrome.\u00a0 Background Sebaceous gland neoplasms such as adenoma, epithelioma, and carcinoma may be associated with Muir-Torre syndrome (MTS).\u00a0 MTS is a rare autosomal dominant genodermatosis characterized by cutaneous sebaceous gland neoplasms and\/or keratoacanthomas associated with visceral maligna&#8230; \u00a0\u00a0<a title=\"Immunohistochemical Screening for Muir-Torre Syndrome\" href=\"https:\/\/deltadermpath.com\/index.php\/immunohistochemical-screening-for-muir-torre-syndrome\/\"><span style=\"color: #3366ff;\">read more &gt;&gt;<\/span><\/a><\/p>\n<h4><a title=\"Melanoma BRAF Testing\" href=\"https:\/\/deltadermpath.com\/index.php\/melanoma-braf-testing\/\"><span style=\"color: #3366ff;\">MELANOMA BRAF TESTING<\/span><\/a><\/h4>\n<p>We are pleased to announce that we now offer BRAF testing to aid in the molecular sub classification of malignant melanoma. \u00a0The test is offered through our molecular pathology division, Delta MDx\u00a0 (www.DeltaMDx.com). Background B-Raf is a member of the Raf kinase family of serine\/threonine-specific protein kinases. This protein plays a role in regulating the RAF-ERK signaling pathway, which affects cell division, differentiation, and secretion (1).\u00a0 The gene encoding thi&#8230; \u00a0\u00a0<a title=\"Melanoma BRAF Testing\" href=\"https:\/\/deltadermpath.com\/index.php\/melanoma-braf-testing\/\"><span style=\"color: #3366ff;\">read more &gt;&gt;<\/span><\/a><\/p>\n<h4><a title=\"Our thoughts on Photomicrographs on Pathology Reports\" href=\"https:\/\/deltadermpath.com\/index.php\/news\/our-thoughts-on-photomicrographs-on-pathology-reports\/\"><span style=\"color: #3366ff;\">OUR THOUGHTS ON PHOTOMICROGRAPHS ON PATHOLOGY REPORTS<\/span><\/a><\/h4>\n<p>Some laboratories include photomicrographs on their pathology reports and these are often marketed as a value added service, as part of a more sophisticated report, or as somehow beneficial to the patient.\u00a0 Delta Dermatopathology does not include photomicrographs on our reports.\u00a0 This is part of a conservative approach with the following considerations in mind: Photomicrographs in pathology reports potentially transfer a portion of the medical-legal liability from the path&#8230; \u00a0<span style=\"color: #3366ff;\">\u00a0<a title=\"Our thoughts on Photomicrographs on Pathology Reports\" href=\"https:\/\/deltadermpath.com\/index.php\/news\/our-thoughts-on-photomicrographs-on-pathology-reports\/\">read more &gt;&gt;<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MELANOMA FISH TEST We are pleased to announce that we now offer fluorescent in situ hybridization (FISH) testing as a diagnostic tool to aid in the classification of histologically ambiguous melanocytic lesions. The test is offered through our molecular pathology\/cytogenetics division, Delta MDx (www.DeltaMDx.com). Background The vast majority of benign nevi can be distinguished from [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-119","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/deltadermpath.com\/index.php?rest_route=\/wp\/v2\/pages\/119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/deltadermpath.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/deltadermpath.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/deltadermpath.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/deltadermpath.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=119"}],"version-history":[{"count":4,"href":"https:\/\/deltadermpath.com\/index.php?rest_route=\/wp\/v2\/pages\/119\/revisions"}],"predecessor-version":[{"id":141,"href":"https:\/\/deltadermpath.com\/index.php?rest_route=\/wp\/v2\/pages\/119\/revisions\/141"}],"wp:attachment":[{"href":"https:\/\/deltadermpath.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}